Autoimmunity and COVID

The discussion explores how COVID-19 can trigger an autoimmune response in some individuals, leading to the production of autoantibodies that may worsen symptoms over time. Researchers are uncovering the complexities of these immune responses, highlighting the role of cytokines and lymphocytes in the disease's progression. As understanding deepens, new treatment possibilities may emerge for those suffering from lingering effects post-infection.